Study of an antifungal drug for ICU patients with fungal infections
Part of Infections clinical trials.
This study tests a medicine called isavuconazole, which is used to treat serious fungal infections. It aims to see if it is safe and works well in very sick patients in the intensive care unit (ICU).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the intensive care unit (ICU).
- You have a suspected or confirmed fungal infection.
- You do not have a history of allergic reaction to this medicine.
- You do not have a rare heart rhythm problem called short QT syndrome.
- You are able to take medicine by mouth or through a feeding tube.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study monitors how the antifungal drug isavuconazole works in children's bodies. It aims to find the right dose for treating serious fungal infections.
This trial tests whether a medicine called rezafungin can help prevent serious fungal infections in people who have received a liver transplant. If you have certain risk factors, this study may offer extra protection against infections.
This study looks at how to best personalize the dose of the antifungal drug isavuconazole for older adults (60+) with serious fungal infections. By measuring drug levels in the blood, doctors hope to make treatment safer and more effective.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This study tests a new antifungal drug (EL219) compared to two standard treatments (liposomal amphotericin B or voriconazole) for people with weakened immune systems who have a suspected or confirmed mold infection. The goal is to see if the new drug works as well or better at treating the infection.
This trial tests a stronger antifungal medicine (liposomal amphotericin B) for people with a serious fungal lung infection who also have liver problems. It aims to see if this treatment is safe and effective for ICU patients.
Hear when a new Fungal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.